SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Goodman who wrote (791)6/9/1997 4:26:00 PM
From: Larry Hartman   of 1172
 
It is the news of the impending dilution that should impact the stock, well before the actual dilution itself. From what I understand, CMTR did really need the money because business is taking longer to kick in than expected (particularly the H. Pylori test kickoff). However, the Coloncare and Cholestrol products are starting to sell better (from what I hear) and should be decent revenue producers in the future. The rapid AIDS test could be huge, but once again, its another long term prospect. Dilution sucks, but it appears to be necessary at this point to pull off the long term business plan. This stock has required inordinate patience and evidently it continues to.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext